← Back

Research · Supplements

Red vine leaf

Three placebo-controlled trials of the AS 195 extract found smaller leg volume or circumference in chronic venous insufficiency. Volume fell by about 20 to 100 mL more than placebo over 12 weeks. A systematic review of five trials found improvements in only some of them. In the largest trial, only leg pain changed among symptoms, and tolerability matched placebo.

Add to Bio HackChecked 2026-11-09
Status
Dietary supplement in the US. Not FDA-approved for any condition.
Also called
AS 195, Antistax, red vine leaf extract, Vitis vinifera leaf, folia vitis viniferae, grape leaf extract
Taken for
chronic venous insufficiency, varicose veins, leg swelling, swelling, edema, heavy legs, leg pain

Strong several reviews agree · Moderate one review or consistent trials · Limited one or a few small studies · Untested no study in people, listed with what it rests on

Reported risks0

No risks sourced yet.

What people take it for, and what was found

Shown to help2

Moderate

Leg swelling in chronic venous insufficiency

Shown to reduce leg volume and swelling in adults with chronic venous insufficiency over 6 to 12 weeks, all with one branded extract.

The numbers and sources
Effect
In 248 patients, 720 mg a day for 12 weeks reduced lower limb volume by 19.9 mL more than placebo (95% CI -37.5 to -2.3) [1]. In 257 patients, 360 mg and 720 mg once a day for 12 weeks gave lower leg volumes 75.9 g (95% CI -106.1 to -45.8) and 99.9 g (95% CI -130.3 to -69.6) below placebo, measured as displaced water, with smaller calf circumference [2]. In a crossover trial of 71 patients, 360 mg a day for 6 weeks reduced ankle circumference by 0.39 cm while it rose 0.29 cm on placebo, and calf circumference by 0.54 cm against a rise of 0.14 cm [3]. A systematic review of 5 trials found that leg volume and circumference improved in only some trials [4].
Population
Adults with chronic venous insufficiency, CEAP grades 3 to 4a [1], stages I to II [2][3].
Sources
[1], [2], [3], [4]
Caveats
All trials tested one branded extract. The review authors call for higher-quality trials [4].
Limited

Leg pain, heaviness and tension

Limited evidence: leg pain fell slightly more than on placebo, while trials disagreed on heaviness, tingling and tension.

The numbers and sources
Effect
In the 248-patient trial, leg pain fell by 6.6 mm more than placebo on a 100 mm scale (95% CI -13.1 to -0.1). Other symptoms did not change significantly [1]. In the 257-patient trial, key venous symptoms improved more in both extract groups than on placebo at 12 weeks (p < 0.001) [2]. The systematic review found heavy and tired legs, tingling, pain and tension improved in only some trials [4].
Population
Adults with chronic venous insufficiency [1][2][4].
Sources
[1], [2], [4]
Caveats
The two largest trials disagree on symptoms other than pain [1][2]. In the 248-patient trial, patients' overall rating of efficacy did not track measured volume change [1].

Doses studied

Trials used 360 mg or 720 mg of AS 195 once a day for 6 to 12 weeks [1][2][3].

Risks

Checked, no increase found1

Limited

Adverse events in trials

Limited evidence: tolerability was similar to placebo in trials of 12 weeks or less.

The numbers and sources
Effect
In the 248-patient trial, tolerability was similar to placebo [1]. The systematic review found tolerability reported as satisfactory or better [4].
Population
Adults with chronic venous insufficiency [1][4].
Sources
[1], [4]
Caveats
Trials lasted 12 weeks or less, so longer use was not studied.

Sources

  1. Rabe E, Stücker M, Esperester A, et al. Efficacy and tolerability of a red-vine-leaf extract in patients suffering from chronic venous insufficiency, results of a double-blind placebo-controlled study. European Journal of Vascular and Endovascular Surgery. 2011. https://doi.org/10.1016/j.ejvs.2010.12.003
  2. Kiesewetter H, Koscielny J, Kalus U, et al. Efficacy of orally administered extract of red vine leaf AS 195 (folia vitis viniferae) in chronic venous insufficiency (stages I-II). A randomized, double-blind, placebo-controlled trial. Arzneimittelforschung. 2000. https://pubmed.ncbi.nlm.nih.gov/10719612/
  3. Kalus U, Koscielny J, Grigorov A, et al. Improvement of cutaneous microcirculation and oxygen supply in patients with chronic venous insufficiency by orally administered extract of red vine leaves AS 195: a randomised, double-blind, placebo-controlled, crossover study. Drugs in R&D. 2004. https://doi.org/10.2165/00126839-200405020-00001
  4. Azhdari M, Zilaee M, Karandish M, et al. Red vine leaf extract (AS 195) can improve some signs and symptoms of chronic venous insufficiency, a systematic review. Phytotherapy Research. 2020. https://doi.org/10.1002/ptr.6705

Everything in the library